Literature DB >> 15901955

Optical biopsy of breast tissue using differential path-length spectroscopy.

Robert L P van Veen1, Arjen Amelink, Marian Menke-Pluymers, Carmen van der Pol, Henricus J C M Sterenborg.   

Abstract

Differential path-length spectroscopy (DPS) was used to determine the local optical properties of breast tissue in vivo. DPS measurements were made on healthy and malignant breast tissue using a fibre-optic needle probe, and were correlated to the histological outcome of core-needle biopsies taken from the same location as the measurements. DPS yields information on the local tissue blood content, the local blood oxygenation, the average micro-vessel diameter, the beta-carotene concentration and the scatter slope. Our data show that malignant breast tissue is characterized by a significant decrease in tissue oxygenation and a higher blood content compared to normal breast tissue.

Entities:  

Mesh:

Year:  2005        PMID: 15901955     DOI: 10.1088/0031-9155/50/11/009

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  23 in total

1.  Automated classification of breast pathology using local measures of broadband reflectance.

Authors:  Ashley M Laughney; Venkataramanan Krishnaswamy; Pilar Beatriz Garcia-Allende; Olga M Conde; Wendy A Wells; Keith D Paulsen; Brian W Pogue
Journal:  J Biomed Opt       Date:  2010 Nov-Dec       Impact factor: 3.170

Review 2.  Advances in optical spectroscopy and imaging of breast lesions.

Authors:  Stavros G Demos; Abby J Vogel; Amir H Gandjbakhche
Journal:  J Mammary Gland Biol Neoplasia       Date:  2006-04       Impact factor: 2.673

3.  Method of detecting tissue contact for fiber-optic probes to automate data acquisition without hardware modification.

Authors:  Sarah Ruderman; Scott Mueller; Andrew Gomes; Jeremy Rogers; Vadim Backman
Journal:  Biomed Opt Express       Date:  2013-07-23       Impact factor: 3.732

4.  System analysis of spatial frequency domain imaging for quantitative mapping of surgically resected breast tissues.

Authors:  Ashley M Laughney; Venkataramanan Krishnaswamy; Tyler B Rice; David J Cuccia; Richard J Barth; Bruce J Tromberg; Keith D Paulsen; Brian W Pogue; Wendy A Wells
Journal:  J Biomed Opt       Date:  2013-03       Impact factor: 3.170

5.  Scanning, non-contact, hybrid broadband diffuse optical spectroscopy and diffuse correlation spectroscopy system.

Authors:  Johannes D Johansson; Miguel Mireles; Jordi Morales-Dalmau; Parisa Farzam; Mar Martínez-Lozano; Oriol Casanovas; Turgut Durduran
Journal:  Biomed Opt Express       Date:  2016-01-15       Impact factor: 3.732

6.  Broadband hyperspectral imaging for breast tumor detection using spectral and spatial information.

Authors:  Esther Kho; Behdad Dashtbozorg; Lisanne L de Boer; Koen K Van de Vijver; Henricus J C M Sterenborg; Theo J M Ruers
Journal:  Biomed Opt Express       Date:  2019-08-07       Impact factor: 3.732

7.  Role of optical spectroscopy using endogenous contrasts in clinical cancer diagnosis.

Authors:  Quan Liu
Journal:  World J Clin Oncol       Date:  2011-01-10

8.  Quantitative optical spectroscopy: a robust tool for direct measurement of breast cancer vascular oxygenation and total hemoglobin content in vivo.

Authors:  J Quincy Brown; Lee G Wilke; Joseph Geradts; Stephanie A Kennedy; Gregory M Palmer; Nirmala Ramanujam
Journal:  Cancer Res       Date:  2009-03-17       Impact factor: 12.701

9.  Scatter spectroscopic imaging distinguishes between breast pathologies in tissues relevant to surgical margin assessment.

Authors:  Ashley M Laughney; Venkataramanan Krishnaswamy; Elizabeth J Rizzo; Mary C Schwab; Richard J Barth; Brian W Pogue; Keith D Paulsen; Wendy A Wells
Journal:  Clin Cancer Res       Date:  2012-08-20       Impact factor: 12.531

10.  Fluorescence spectroscopy: an adjunct diagnostic tool to image-guided core needle biopsy of the breast.

Authors:  Changfang Zhu; Elizabeth S Burnside; Gale A Sisney; Lonie R Salkowski; Josephine M Harter; Bing Yu; Nirmala Ramanujam
Journal:  IEEE Trans Biomed Eng       Date:  2009-03-04       Impact factor: 4.538

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.